002007.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:04):

Stats
Today's Volume	9.20M
Average Volume	10.95M
Market Cap	34.80B
EPS	CNY0 ( 2024-04-22 )
Next earnings date	( CNY0.130 ) 2024-04-26
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	23.51
ATR14	CNY0.0120 (0.06%)

Volume Correlation

Long: -0.08 (neutral)

Short: -0.56 (weak negative)

Signal:(48.578) Neutral

Hualan Biological Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hualan Biological Correlation - Currency/Commodity

0.55
( weak )

0.46
( neutral )

0.00
( neutral )

-0.04
( neutral )

-0.74
( moderate negative )

0.17
( neutral )

Hualan Biological Financials

Annual	2023
Revenue:	CNY5.30B
Gross Profit:	CNY3.56B (67.30 %)
EPS:	CNY0.810

Q4	2023
Revenue:	CNY1.42B
Gross Profit:	CNY954.78M (67.34 %)
EPS:	CNY0.230

Q3	2023
Revenue:	CNY2.33B
Gross Profit:	CNY1.78B (76.42 %)
EPS:	CNY0.300

Q2	2023
Revenue:	CNY704.58M
Gross Profit:	CNY390.63M (55.44 %)
EPS:	CNY0.0959

Financial Reports:

No articles found.

Hualan Biological

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.

Realtime updates for Hualan Biological [002007.SZ]

Upcoming Earnings Alert